Search results for "Artesunate"

showing 10 items of 35 documents

Abstract 5109: Beyond malaria: Second career of artesunate as cancer drug

2017

Abstract More than a decade ago, we initiated a research program on the molecular pharmacology of phytochemicals derived from Chinese medicinal herbs. Bioactive plant extracts have been fractionated by chromatographic techniques. We isolated bioactive compounds and elucidated their chemical structures by nuclear magnetic resonance and mass spectrometry. A promising compounds was artemisinin from Artemisia annua L. and its semisynthetic compound artesunate. Artemisinin and artesunate are anti-malarial drugs. Our data indicated profound activity against cancer cells, but also against various viruses, Schistosoma, Trypanosoma, and even plant crown gall tumors. To elucidate the molecular mode o…

DrugCancer Researchbiologybusiness.industrymedia_common.quotation_subjectArtemisia annuaCancerDrug resistancePharmacologymedicine.diseasebiology.organism_classificationchemistry.chemical_compoundOncologychemistryArtesunatePharmacogenomicsCancer cellMedicineArtemisininbusinessmedia_commonmedicine.drugCancer Research
researchProduct

The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65.

2015

Infection with human cytomegalovirus (HCMV) is a serious medical problem, particularly in immunocompromised individuals and neonates. The success of standard antiviral therapy is hampered by low drug compatibility and induction of viral resistance. A novel strategy is based on the exploitation of cell-directed signaling inhibitors. The broad antiinfective drug artesunate (ART) offers additional therapeutic options such as oral bioavailability and low levels of toxic side-effects. Here, novel ART-derived compounds including dimers and trimers were synthesized showing further improvements over the parental drug. Antiviral activity and mechanistic aspects were determined leading to the followi…

DrugHuman cytomegalovirusTranscriptional Activationmedia_common.quotation_subjectTranscription Factor RelAArtesunateCytomegalovirusPharmacologyCREBAntiviral Agentschemistry.chemical_compoundVirologyDrug Resistance ViralmedicineHumansCyclic AMP Response Element-Binding ProteinHerpesviridaemedia_commonPharmacologybiologyHEK 293 cellsNF-kappa BTranscription Factor RelANF-κBmedicine.diseaseIn vitroArtemisininsUp-RegulationHEK293 CellschemistryMutationbiology.proteinSignal transductionSignal TransductionAntiviral research
researchProduct

Commentary. Regulation of drug and immune resistance by YY1 in cancer.

2010

DrugYY1business.industrymedia_common.quotation_subjectImmune resistanceCancermedicine.diseaseBiochemistryDrug resistance YY1 NF-kB artesunateImmunologyGeneticsmedicineSettore BIO/14 - FarmacologiaMolecular MedicinebusinessBiotechnologymedia_common
researchProduct

Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin

2013

Artemisinin is a drug, widely used in malaria treatment. As the binding affinity of artemisinin and its derivatives dihydroartemisinin and artesunate to blood serum proteins might influence the effectiveness of the drug, binding of artemisinin and derivatives to serum albumin was studied under near physiological conditions. Binding kinetics indicate a simple, single-step association process for all artemisinin derivatives. The determined changes in enthalpy and entropy upon drug binding clearly indicate that hydrophobic forces are most important for artemisinin and dihydroartemisinin binding, whereas binding of artesunate is governed by both hydrophilic and hydrophobic forces. Key residues,…

Drugmedia_common.quotation_subjectmedicine.medical_treatmentSerum albuminArtesunatePharmaceutical ScienceDihydroartemisininPharmacologyHydrophobic effectchemistry.chemical_compoundBlood serumparasitic diseasesDrug DiscoverymedicineAnimalsArtemisininSerum Albuminmedia_commonPharmacologybiologyChemistryArtemisininsReceptor–ligand kineticsMalariaComplementary and alternative medicineBiochemistryArtesunatebiology.proteinMolecular MedicineCattleDrug Therapy CombinationHydrophobic and Hydrophilic InteractionsProtein Bindingmedicine.drugPhytomedicine
researchProduct

Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells

2015

Abstract Background Apoptosis and other forms of cell death have been intensively investigated in the past years to explain the mode of action of synthetic anticancer drugs and natural products. Recently, a new form of cell death emerged, which was termed ferroptosis, because it depends on intracellular iron. Here, the role of genes involved in iron metabolism and homeostasis for the cytotoxicity of ten artemisinin derivatives have been systematically investigated. Material and methods Log10IC50 values of 10 artemisinin derivatives (artesunate, artemether, arteether, artenimol, artemisitene, arteanuin B, another monomeric artemisinin derivative and three artemisinin dimer molecules) were co…

IronArtesunatePharmaceutical ScienceApoptosisTransferrin receptorDeferoxaminePhenylenediaminesPharmacologyBiologyInhibitory Concentration 50chemistry.chemical_compoundCell Line Tumorparasitic diseasesDrug DiscoverymedicineHumansArtemetherArtemisininCytotoxicityOligonucleotide Array Sequence AnalysisPharmacologychemistry.chemical_classificationCyclohexylaminesCell DeathMolecular StructureArtemisinin DimerArtemisininsGene Expression Regulation NeoplasticComplementary and alternative medicinechemistryApoptosisTransferrinArtesunateMolecular MedicineArtemethermedicine.drugPhytomedicine
researchProduct

Antischistosomal activity of artemisinin derivatives in vivo and in patients

2016

Schistosomiasis is a helminthic disease affecting more than 200 million people in the tropics as well as returning travellers. Treatment mainly relies on a single drug, praziquantel. Praziquantel cannot kill developing schistosomula resulting in frequent treatment failures and re-infections. Monotherapy also favors the selection for resistance. New drugs are therefore urgently needed. The activity of the semi-synthetic artemisinin derivatives artemether, artesunate and arteether is not restricted to malaria. We reviewed their anti-schistosomal activity in vivo and in patients by searching the PubMed database for publications since 1983 with the search terms "artemisinin" and "Schistosoma". …

Male0301 basic medicineCombination therapyArtesunateSchistosomiasisPharmacologySchistosomicides03 medical and health scienceschemistry.chemical_compoundparasitic diseasesmedicineAnimalsHumansSchistosomiasisArtemetherArtemisininParasite Egg CountSchistosomaPharmacologybiologymedicine.diseasebiology.organism_classificationArtemisininsPraziquantelTreatment Outcome030104 developmental biologychemistryArtesunateImmunologySchistosomaFemaleArtemetherMalariamedicine.drugPharmacological Research
researchProduct

A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer.

2015

Background Artesunate is an antimalarial agent with broad anti-cancer activity in in vitro and animal experiments and case reports. Artesunate has not been studied in rigorous clinical trials for anticancer effects. Aim To determine the anticancer effect and tolerability of oral artesunate in colorectal cancer (CRC). Methods This was a single centre, randomised, double-blind, placebo-controlled trial. Patients planned for curative resection of biopsy confirmed single primary site CRC were randomised (n = 23) by computer-generated code supplied in opaque envelopes to receive preoperatively either 14 daily doses of oral artesunate (200 mg; n = 12) or placebo (n = 11). The primary outcome meas…

MaleColorectal cancerResistancelcsh:MedicineAdministration OralArtesunatePilot ProjectsPharmacologyGastroenterologyPlacebosNeutropaeniachemistry.chemical_compoundCancerlcsh:R5-920medicine.diagnostic_testGeneral MedicineImmunohistochemistryArtemisininsDihydroartemisininTreatment OutcomeTolerabilityOriginal ArticleFemalelcsh:Medicine (General)Colorectal NeoplasmsKi67medicine.medical_specialtyRandomizationPlaceboGeneral Biochemistry Genetics and Molecular BiologyDouble-Blind MethodMedian follow-upInternal medicineBiopsymedicineBiomarkers TumorHumansAgedDemographyStaining and Labelingbusiness.industrylcsh:Rmedicine.diseaseColorectal cancerSurvival AnalysisCarcinoembryonic AntigenMalariaClinical trialKi-67 AntigenchemistryArtesunateCommentarybusinessEBioMedicine
researchProduct

Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma.

2015

Abstract Background Artemisia annua L, artemisinin and artesunate reveal profound activity not only against malaria, but also against cancer in vivo and clinical trials. Longitudinal observations on the efficacy of A. annua in patients are, however missing as of yet. Methods Clinical diagnosis was performed by imaging techniques (MRT, scintigraphy, SPECT/CT) and blood examinations of standard parameters from clinical chemistry. Immunohistochemistry of formalin-fixed, paraffin-embedded tumor material was performed to determine the expression of several biomarkers (cycloxygenase-2 (COX2), epidermal growth factor receptor (EGFR), glutathione S-transferase P1 (GSTP1), Ki-67, MYC, oxidized low d…

MalePathologymedicine.medical_specialtyArtemisia annuaPharmaceutical ScienceArtesunateBone NeoplasmsArtemisia annuaScintigraphyProstate cancerCell Line TumorDrug DiscoveryBiopsymedicineBiomarkers TumorHumansNeoplasm MetastasisTumor markerPharmacologyAged 80 and overbiologymedicine.diagnostic_testCancerProstatic NeoplasmsProstate-Specific Antigenbiology.organism_classificationmedicine.diseaseImmunohistochemistryArtemisininsProstate-specific antigenComplementary and alternative medicineVascular endothelial growth factor CDrug Resistance NeoplasmCancer researchMolecular MedicinePhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein surviv…

2011

Abstract Background and purpose Novel strategies to overcome an irradiation resistant phenotype may help to increase therapeutic efficacy in glioblastoma multiforme. The present study aimed to elucidate radiation sensitizing properties of artesunate, a semi synthetic derivate of artemisinin and to assess factors involved in this effect. Materials and methods LN229 and U87MG cells were treated with various concentrations of artesunate and radiation response was determined by a colony forming assay. Cell numbers, apoptosis induction, cell cycle distribution, and DNA repair following combined modality treatment were monitored by MTT-, caspase 3/7 assay, cytofluorometry, and γ-H2AX foci formati…

Radiation-Sensitizing AgentsDNA RepairCell SurvivalSurvivinArtesunateDown-RegulationCaspase 3ApoptosisInhibitor of apoptosisInhibitor of Apoptosis Proteinschemistry.chemical_compoundCell Line TumorSurvivinHumansRadiology Nuclear Medicine and imagingClonogenic assayDose-Response Relationship DrugBrain NeoplasmsCell CycleHematologyCell cycleArtemisininsXIAPNeoplasm ProteinsOncologychemistryArtesunateApoptosisCancer researchGlioblastomaRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

Coronaviral Ion Channels as Target for Chinese Herbal Medicine

2012

Traditional medicinebusiness.industryPharmacologymedicine.disease_causeBiochemistryVirus Releasechemistry.chemical_compoundchemistryArtesunateGeneticsMolecular MedicineMedicinebusinessIon channelBiotechnologyCoronavirusForum on Immunopathological Diseases and Therapeutics
researchProduct